This dual approach may help maintain more stable glutathione levels between injections while supporting cellular synthesis pathways
In one trial, 16 people placed on experimental bed rest for 3 weeks (in order to increase urinary calcium excretion by causing bone breakdown) and treated with 20 mg per day of the bisphosphonate alendronate had lower urine calcium concentrations, and lower calcium oxalate and calcium phosphate saturations, compared with placebo (Ruml 1995)
However, at the same time, the reviews do note the absence of some data, particularly the lack of information on higher doses
With its potent ability to cause the reverse, it also soothes some inflammation-initiated conditions
What that means for efficacy claims The volume of preclinical BPC-157 literature is sometimes cited as evidence that the compound "works." It is important to understand what preclinical evidence does and does not establish
Occasionally, there may be slight redness or tenderness at the injection site, but this will fade quickly
